Johnson & Johnson
Johnson & Johnson (NYSE:JNJ) is one of the biggest holdings in the entire Berkshire Hathaway portfolio. While many other health care stocks are in the lineup, the 29 million shares of J&J add up to a position of roughly $1.8 billion dollars.
Unlike the aforementioned GSK, however, J&J is a health care company focused on consumers and drug stores as much as doctors and hospitals. That’s because J&J is behind big brands including Tylenol and Band-Aids, just to name a few polestars of its consumer health division. Reliable sales from these products adds up to a healthy yield of 3.6% at current valuations.
Dividends have been paid since 1944, and a dividend increase announced just a few weeks ago proves Johnson & Johnson cares about keeping income-oriented investors happy.